Evidence-Based Oncology™
About the Journal
Mission: AJMC: Evidence-Based Oncology (EBO) is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, policy experts, providers, and other stakeholders associated with cancer care. EBO’s mission is to publish research and commentaries relevant to clinical decision makers and policy makers as they work to promote the efficient delivery of high-quality cancer care.
Readership: EBO circulates to over 21,300 individuals with important decision-making responsibilities who direct as well as influence utilization of health care resources. Our audience includes health plan medical and pharmacy directors, clinical oncology leadership (medical and pharmacy) from academic and community practices, oncology practice managers, employers, and benefit consultants.
